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Abstract 
Background: Right ventricular (RV) free wall fibrosis is an important component of adverse remodeling with RV 
dysfunction in pulmonary hypertension (PH). However, no previous reports have compared cardiovascular magnetic 
resonance (CMR) findings and histological analysis for RV free wall fibrosis in PH. We aimed to assess the feasibility of 
CMR T1 mapping with extracellular volume fraction (ECV) for evaluating the progression of RV free wall fibrosis in PH, 
and compared imaging findings to histological collagen density through an animal study.
Methods: Among 42 6‑week‑old Wistar male rats, 30 were classified according to disease duration (baseline before 
monocrotaline injection, and 2, 4, 6 and 8 weeks after injection) and 12 were used to control for aging (4 and 8 weeks 
after the baseline). We obtained pre and post‑contrast T1 maps for native T1 and ECV of RV and left ventricular (LV) 
free wall for six animals in each disease‑duration group. Collagen density of RV free wall was calculated with Masson’s 
trichrome staining. The Kruskall‑Wallis test was performed to compare the groups. Native T1 and ECV to collagen 
density were analyzed with Spearman’s correlation.
Results: The mean values of native T1, ECV and collagen density of the RV free wall at baseline were 1541 ± 33 ms, 
17.2 ± 1.3%, and 4.7 ± 0.5%, respectively. The values of RV free wall did not differ according to aging (P = 0.244, 0.504 
and 0.331, respectively). However, the values significantly increased according to disease duration (P < 0.001 for all). 
Significant correlations were observed between native T1 and collagen density (r = 0.770, P < 0.001), and between ECV 
and collagen density for the RV free wall (r = 0.815, P < 0.001) in PH. However, there was no significant difference in 
native T1 and ECV values for the LV free wall according to the disease duration from the baseline (P = 0.349 and 0.240, 
respectively).
Conclusions: We observed significantly increased values for native T1 and ECV of the RV free wall without significant 
increase of the LV free wall according to the disease duration of PH, and findings were well correlated with histological 
collagen density.
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Background
In pulmonary hypertension (PH), the right ventricle 
(RV) is compromised by high pressure, which leads to 
RV cavity dilatation, dysfunction, and fibrosis. Because 
RV performance is an indicator of disease severity and 
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a predictor of survival in PH, there is great interest in 
new imaging techniques that allow early detection of RV 
involvement [1–3]. Although echocardiography provides 
some information on RV structure and function [4], car-
diovascular magnetic resonance (CMR) has become the 
gold standard in this regard due to the structural com-
plexity of the RV [5]. However, until now, the greatest 
advantage of CMR for the RV has been its high-resolu-
tion cine imaging rather than contrast-enhanced myocar-
dial fibrosis imaging.
While left ventricular (LV) fibrosis is readily evaluated 
with CMR using late gadolinium enhancement (LGE) 
imaging and T1 mapping with the extracellular volume 
fraction (ECV) [6–8], there are technical difficulties when 
assessing RV free wall fibrosis because of insufficient spa-
tial resolution due to the thinness of the RV wall. Hence, 
the assessment of myocardial fibrosis in PH has been lim-
ited to ventricular septal insertion points (SIPs) rather 
than the RV free wall [9–11]. However, because RV free 
wall fibrosis is also a significant feature of PH, it should 
be regarded as an important component of adverse 
remodeling with RV dysfunction [12]. Recently, advances 
in CMR native T1 mapping have enabled higher spatial 
resolution and shown increases in native T1 and ECV 
for the RV free wall in PH patients, with these findings 
being associated with decreased RV function [13–15]. 
Moreover, T1 mapping with ECV might make it feasible 
to evaluate gradual changes in diffuse interstitial fibrosis 
in the overloaded RV of PH in contrast to LGE imaging, 
which can primarily detect focal areas of fibrosis with its 
dichotomous nature. However, no reports have yet com-
pared native T1 mapping with ECV and histological anal-
ysis for tissue characterization of the RV free wall in PH. 
Therefore, we aimed to assess whether it was possible 
to use T1 mapping with ECV to evaluate the sequential 
progression of RV free wall fibrosis in PH, and compare 




All experiments were approved by the Animal Care 
and Use Committee of our institution, and we per-
formed experiments according to the National Insti-
tutes of Health guidelines. A total of 46 6-week-old 
Wistar male rats were used. A single subcutaneous injec-
tion of monocrotaline (40  mg/kg) (Sigma Chemical, St. 
Louis, Missouri, USA) was used to induce PH [16, 17]. 
Animals were divided into 5 groups according to dis-
ease duration; baseline before injection, and 2, 4, 6 and 
8 weeks after injection, respectively. Among 46 animals, 
4 expired before the study was completed (1 at 4 weeks, 
1 at 6 weeks, and 2 at 8 weeks), and 6 animals allocated 
to each of the 5 disease-duration groups. The remaining 
12 6-week-old Wistar male rats were used to control for 
confounding factors thought to arise from aging, and 6 
animals were assigned to each group after 4  weeks and 
8 weeks after the baseline time point without monocro-
taline injection. The weight of each animal was measured 
immediately before CMR scanning to calculate body sur-
face area [18]. Venous blood samples were obtained from 
the tail vein for hematocrit levels to calculate ECV.
Cardiovascular magnetic resonance imaging
All CMR images were acquired through a 9.4  T small 
animal CMR scanner (Bruker Biospin, Billerica, Mas-
sachusetts, USA) with an 86-mm volume transmit coil 
and a 4-channel phased-array surface coil. CMR was 
performed under spontaneous ventilation with anes-
thesia by inhalation of 2% isoflurane. Cine images in the 
short-axis planes were acquired using a self-gated fast 
low-angle shot sequence (IntraGate, Bruker BioSpin, 
ParaVision 5.1) with the following parameters: TR/TE, 
5/2.3 ms; flip angle, 10°; field of view, 40 × 40 mm; pixel 
size, 0.32 × 0.32  mm2; section thickness, 2  mm; num-
ber of slice, 8—9; and cardiac phase, 25. Pre-contrast 
T1 maps were acquired in the short axis planes using a 
respiratory  navigated Look-Locker inversion recovery 
imaging [19] (Additional file  1: Fig. S1). The sequence 
was proposed to provide higher motion robustness so 
that the myocardial T1 maps could be accurately meas-
ured in small animals with higher heart rates and res-
piratory rates. The sequence is based on the Look-Locker 
sequence, which continuously acquires  with a spoiled 
gradient-echo readout sequence during T1 recovery fol-
lowing the inversion pulse (IR)  without respiratory gat-
ing. Therefore, the  sequence is more suitable for small 
animals with heart rates of 300–400  bpm. In this T1 
mapping sequence, image data was acquired consecu-
tively during T1 recovery process with electrocardio-
graphic (ECG) gating. Respiratory motion compensated 
IR-weighted images were reconstruced  using a self-gat-
ing method that estimates respiratory motion from the 
acquired image data itself [20]. Scanning parameters 
were as follows: TR/TE, 15/1.52  ms, flip angle, 8°; field 
of view, 40 × 40  mm, pixel size = 0.2 × 0.2  mm2; section 
thickness, 1.5  mm; slice gap, 1.5  mm; acquisition dura-
tion, 16 heart beats; number of slice, 3; and relaxation 
duration, 5000 ms. The RV myocardial thickness of nor-
mal Wistar male rats was approximately 0.6 mm in dias-
tole and 0.9 mm in systole. The relative spatial resolution 
was 0.2 × 0.2  mm2. Post-contrast T1 maps were obtained 
with the same protocol 15  min after administration of 
the contrast agent (gadoterate meglumine, 0.2 mmol/kg; 
Dotarem; Guerbet, Roissy, France). T1 maps were gener-
ated by applying three-parameter non-linear least square 
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fitting on a pixel-by-pixel basis for the motion-corrected 
phase-sensitive inversion recovery images  and then 
Look-Locker correction [21].
All CMR images were evaluated with commercially 
available software (cvi42; Circle Cardiovascular Imag-
ing, Calgary, Alberta, Canada). Two radiologists (Y.J.H. 
and H-J.L. with 10 and 12 years of experience in cardio-
vascular imaging) reviewed the images in consensus and 
were blinded to disease duration. From the short-axis 
cine images, the end-diastolic and systolic volumes of 
both ventricles were calculated by multiplying the areas 
enclosed by the endocardial contours by slice thickness. 
The end-diastolic volume indices (EDVI) were calculated 
by dividing the end-diastolic volume by body surface area 
 (m2). The ejection fraction (EF) was calculated with the 
following equation: (end-diastolic volume − end-systolic 
volume) × 100/end-diastolic volume (%). The ECV was 
measured using pre- and post-contrast T1 maps as fol-
lows: (ΔR1m/ΔR1b) × (1 − hematocrit) × 100 (%), for 
which  R1m is R1 in the myocardium,  R1b is R1 in the 
blood, and ΔR1 is the change in T1 relaxivity before and 
after the contrast agent was administered. T1 measure-
ments were performed on the middle third of the RV 
free wall, septum and LV lateral wall right at the mid-
way between the apex and base of the LV on short axis 
plane. When measuring the middle third of RV free wall, 
the inner junctional points of both ventricles were used 
as positional reference points to match the imaging find-
ings with the histologic findings (Fig. 1). The endo- and 
epicardial borders of the myocardium were delineated 
manually for T1 measurements, and the very edges were 
excluded to reduce partial volume averaging from the 
myocardial-blood interface. Additionally, T1 measure-
ments were done at the anterior and inferior SIPs with 
circular regions of interest (ROI) of approximately 2 
 mm2. Blood T1 values were also measured in the LV cav-
ity while avoiding papillary muscles.
Pathology
After CMR imaging, all hearts were resected and fixed 
in 4% formaldehyde, and sliced in sections approxi-
mately 2-mm thick right at the midway between the 
apex and base of the LV on the short-axis plane. The 
sections were embedded in paraffin and were sliced 
further into 5-µm-thick sections. Afterwards, the 
specimens were stained with H&E and Masson’s tri-
chrome staining. Histologic analysis was performed 
by a pathologist  H.S.S. with 13  years of experience in 
thoracic pathology blinded to disease duration and 
CMR findings. H&E-stained sections were used for the 
overall examination. Masson’s trichrome-stained sec-
tions were digitally scanned with high-power magnifi-
cation (400X) (ImageScope v10.0; Aperio Technologies, 
Vista, California, USA), and the pixel numbers of the 
myocardial tissue and collagen were counted using a 
macro written in ImageJ (National Institute of Health, 
Bethesda, Maryland, USA) based on the thresholding 
algorithms [22, 23]. Collagen density for the RV was 
calculated as the percentage of pixel numbers of col-
lagen to the myocardial tissue within a defined ROI, 
which was the same on T1 maps located at the middle 
one third level of the RV free wall.
Statistical analyses
All statistical analyses were performed with commercially 
available software SPSS Statistics (version 20.0, Statistical 
Package for the Social Sciences, International Business 
Machines, Inc., Armonk, New York, USA). Continuous 
variables are expressed as means ± standard deviations 
using 2 significant figures, and the Kruskall-Wallis test 
was performed to estimate significant differences among 
the groups (from baseline to 8 weeks) for continuous var-
iables. Then for variables with significant differences on 
the Kruskall-Wallis test, the Mann–Whitney U test was 
further performed to analyze the differences between the 
baseline and each disease-duration group, and the differ-
ences between two sequentially adjacent disease-duration 
groups. Because our study was based on an exploratory 
data analysis with animal experiments, we did not use 
the Bonferroni correction for multiple testing. Correla-
tions of native T1 and ECV to collagen density of the RV 
free wall were analyzed with Spearman’s correlation. A P 
value < 0.05 was considered statistically significant.
Fig. 1 A diagram to measure T1 values on the myocardium. Each 
region‑of‑interest (ROI) was drawn on the middle third of the free 
walls of both ventricles (right ventricle (RV) outlined in red and left 
ventricle (LV) outlined in blue) and septum (orange line) based on the 
inner junctional points (red asterisks) in reference to the exact middle 
of the LV on the short axis plane. Additionally, circular ROIs were 
drawn at the anterior (green circle) and inferior (purple circle) septal 
insertion points (SIPs)
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Results
Baseline characteristics
Baseline characters are summarized in Table  1. The 
mean baseline body weight was 267.8 ± 8.1  g, and body 
weight increased according to age and disease duration 
(P < 0.001). The mean hematocrit level for ECV calcula-
tions was 53.8 ± 2.0% at baseline, and increased accord-
ing to age and disease duration (P < 0.001), with 6 weeks 
and 8 weeks showing significantly increased levels com-
pared to the baseline (P = 0.004 and 0.002, respectively). 
The mean heart rate was not significantly different 
according to age and disease duration (P = 0.648).
Cardiac function
The results of cardiac function are described in Fig.  2 
and Additional file  1: Table  S1. The mean baseline val-
ues of RVEDVI and LVEDVI were 10.1 ± 0.4  ml/m2 
and 10.4 ± 0.9  ml/m2, and of RVEF and LVEF were 
67.6 ± 2.0% and 66.3 ± 2.2%, respectively. The mean val-
ues of RVEDVI increased and the mean values of LVEDVI 
decreased according to disease duration (P < 0.001 for 
both) (Fig.  2a). The mean values of RVEF and LVEF 
decreased according to disease duration (P < 0.001 for 
both) (Fig.  2b). For RVEDVI and RVEF, significant dif-
ferences were first observed at 4 weeks compared to the 
baseline (P = 0.004 for both), and the values did not show 
significant differences between 4 and 6 weeks (P = 0.109 
and 0.150, respectively); However, significant differ-
ences were observed between 6 and 8  weeks (P = 0.004 
and 0.025). For LVEDVI, significant differences were 
observed at 6 weeks compared to the baseline (P = 0.004), 
and no significant differences were observed between 6 
and 8 weeks (P = 0.180). For LVEF, significant differences 
were first observed at 4 weeks compared to the baseline 
(P = 0.037). In addition, no significant differences were 
observed between 4 and 6  weeks (P = 0.055), but a sig-
nificant difference was observed between 6 and 8 weeks 
(P = 0.030).
Myocardial native T1 and ECV
The results of myocardial native T1 are described in Fig. 3 
and Additional file 1: Table S2. The mean values of native 
T1 on baseline group were 1541 ± 33 ms, 1552 ± 39 ms, 
1562 ± 42  ms, 1529 ± 42  ms, and 1576 ± 37  ms for the 
Table 1 Results of basic characteristics according to disease duration
Data are means ± standard deviations
*Between the baseline group and each duration group
† Between two sequentially adjacent duration groups
‡ No significant difference seen with the Kruskall–Wallis test (P = 0.648)
Baseline 2 weeks 4 weeks 6 weeks 8 weeks
Body weight (g) 267 ± 8 311 ± 9 343 ± 7 369 ± 12 418 ± 8
P value* 0.002 0.002 0.002 0.002
P  value† 0.002 0.002 0.002 0.002
Hematocrit (%) 53.8 ± 2.0 54.1 ± 1.6 57.0 ± 3.0 60.1 ± 2.7 62.0 ± 2.8
P value* 0.729 0.071 0.004 0.002
P  value† 0.729 0.097 0.132 0.310
Heart rate (bpm)‡ 283 ± 13 282 ± 16 285 ± 15 289 ± 13 296 ± 16
Fig. 2 Sequential progression of cardiac function according to disease duration. Both ventricular end‑diastolic volume indices (EDVI) (a) and both 
ventricular ejection fractions (EF) (b) show significant changes according to disease duration
Page 5 of 9Kim et al. J Cardiovasc Magn Reson           (2021) 23:64  
RV, septum, anterior SIP, inferior SIP, and LV, respec-
tively. The mean values of native T1 for each section 
significantly increased according to disease duration 
(P < 0.001 for the RV and inferior SIP, 0.006 for the sep-
tum, and 0.001 for the anterior SIP, respectively) except 
for the LV (P = 0.349). Significant differences were first 
observed at 6  weeks for the RV and septum (P = 0.004 
and 0.022, respectively), and further significant differ-
ences were observed between 6 and 8 weeks (P = 0.004) 
for the RV, but not for the septum (P = 0.223). For the 
anterior SIP and inferior SIP, the first significant dif-
ference was observed at 4  weeks (P = 0.026 and 0.002, 
respectively), but no further significant differences were 
observed between 4 and 6  weeks (P = 0.180 and 0.132, 
respectively), and between 6 and 8 weeks (P = 0.240 and 
0.310, respectively).
The results of ECV are described in Fig.  4 and Addi-
tional file 1: Table S3, which showed similar patterns to 
those of native T1. The mean values of ECV on base-
line group were 17.2 ± 1.3%, 17.5 ± 2.0%, 17.9 ± 1.5%, 
17.4 ± 2.0%, and 17.7 ± 1.1% for the RV, septum, anterior 
SIP, inferior SIP, and LV, respectively. These mean values 
of ECV showed significant increase according to disease 
duration (P < 0.001 for the RV and inferior SIP, 0.020 for 
the septum, and 0.001 for the anterior SIP, respectively) 
except for the LV (P = 0.240). The first significant differ-
ence compared to the baseline was observed at 6 weeks 
for the RV and septum (P = 0.002 and 0.041, respec-
tively). Additional significant differences between 6 and 
8  weeks were observed for the RV (P = 0.009), but not 
for the septum (P = 0.818). For the mean ECV values of 
the anterior SIP and inferior SIP, significant differences 
were first observed at 4 weeks compared to the baseline 
(P = 0.015 and 0.002, respectively), but with no significant 
differences between 4 and 6 weeks (P = 0.485 and 0.240, 
respectively), and between 6 and 8 weeks (P = 0.818 and 
0.180, respectively).
Histopathology
Animals showed varying degrees of RV hypertrophy 
macroscopically dependent on disease duration. Micro-
scopic analysis found evidence of varying degrees of 
myocyte hypertrophy, interstitial fibrosis, muscular fiber 
disarray, and lymphocytic infiltration with collagen depo-
sition according to disease duration. The mean values of 
collagen density for the RV were 4.7 ± 0.5%, 4.6 ± 0.3%, 
5.2 ± 0.2%, 10.6 ± 0.5%, and 14.0 ± 0.5% at the baseline, 
2  weeks, 4  weeks, 6  weeks, and 8  weeks, respectively 
(Fig.  5). The values significantly increased with disease 
duration (P < 0.001) and showed similar patterns with 
native T1 and ECV of the RV free wall. The first signifi-
cant increase was observed at 6  weeks (P = 0.002) and 
another significant increase was observed between 6 and 
8  weeks (P = 0.002). In addition, significant correlations 
were observed between native T1 and collagen density 
(r = 0.770, P < 0.001), and between ECV and collagen 
density for the RV free wall (r = 0.815, P < 0.001). (Fig. 6 
and Fig. 7).
Fig. 3 Sequential progression of myocardial native T1 according to disease duration. The mean values of native T1 for RV (a), septum (b), anterior 
SIP (c) and inferior SIP (d) significantly increase according to disease duration except for the LV (e)
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Normal control study
The results of the normal control study are described in 
Additional file 1: Table S4. Mean body weight increased 
with age (P < 0.001). However, there were no significant 
differences for mean hematocrit levels and heart rates 
(P = 0.264 and 0.076, respectively). For cardiac function, 
there were no significant differences between RVEDVI 
and LVEDVI (P = 0.244 and 0.147, respectively) as well 
as between RVEF and LVEF (P = 0.171 and 0.580, respec-
tively). When characterizing myocardial tissue, native T1 
values (P = 0.244 and 0.548 for RV and LV, respectively) 
and ECV values (P = 0.504 and 0.291 for RV and LV, 
respectively) of both ventricles showed no significant dif-
ference at baseline, 4 weeks, and 8 weeks. In addition, no 
significant differences were observed for collagen density 
in the RV according to age (P = 0.331).
Discussion
The major finding of our study was the significant 
increase observed in native T1 and ECV values of the 
RV free wall without significant increases in the LV free 
wall according to disease duration, and the results were 
well correlated with collagen density on histopathologi-
cal analysis. In addition, similar patterns of increase were 
observed in native T1, ECV and collagen density of the 
RV free wall with first significance at 6 weeks compared 
to the baseline and then further significance between 6 
and 8 weeks. Through the normal control study, we found 
that no significant difference was observed in the native 
T1 and ECV values of both ventricles according to age. 
T1 mapping with ECV has been associated with dif-
fuse myocardial fibrosis or infiltrates of LV through his-
tological validation [6–8]. In addition, an animal study 
validated the use of T1 mapping with ECV for the serial 
monitoring of chemotherapy-induced cardiotoxicity [24]. 
However, there have been no reports on the RV free wall. 
Therefore, our study results suggest that T1 mapping 
Fig. 4 Sequential progression of myocardial ECV values according to disease duration. The mean values of extracellular volume fraction (ECV) for 
RV (a), septum (b), anterior SIP (c) and inferior SIP (d) significantly increase according to disease duration except for the LV (e)
Fig. 5 Sequential progression of collagen density in the RV free wall 
according to disease duration. The mean values of collagen density 
significantly increase according to disease duration
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with ECV can provide important insight into myocardial 
tissue characteristics and indicate increased fibrosis in 
the RV free wall through histologic comparison.
Furthermore, we observed significant increase in native 
T1 and ECV values of the interventricular septum includ-
ing SIPs as well as the RV free wall according to disease 
duration in animal models. Interestingly, these increases 
Fig. 6 Correlations of native T1 and ECV to collagen density of the RV free wall. Significant correlations were observed between native T1 and 
collagen density, and between ECV and collagen density for the RV free wall
Fig. 7 Representative cases from our study. Myocardial native T1 and ECV values of the RV free wall are 1564 ms and 17.8% from the pre‑ and 
post‑contrast images (a, b), and collagen density is 4.1% on myocardial specimens at baseline (c). Pre‑ and post‑contrast images obtained 6 weeks 
after monocrotaline injection (d, e) show increased native T1 and ECV values for the RV free wall (1672 ms and 24.3%, respectively). Collagen density 
is 11.0% (f). Myocardial specimens refer to myocardial specimens scanned digitally with Masson’s trichrome staining (original magnification × 400)
Page 8 of 9Kim et al. J Cardiovasc Magn Reson           (2021) 23:64 
in the values of each section fluctuated from time to time, 
rather than gradually increasing linearly with time. For 
the anterior SIP and inferior SIP, significant increase in 
fibrosis was detected relatively early at 4 weeks with sig-
nificant changes in both ventricular functions, and there-
after, no further significant changes were observed. Both 
ventricular functions did not show significant changes 
between 4 and 6 weeks, but did show significant changes 
between 6 and 8 weeks. In contrast, significant increases 
in fibrosis were observed for the RV and septum rela-
tively late at 6 weeks, and further significant progression 
was noted for the RV at 8 weeks. From these findings, we 
hypothesized that early changes in the RV function were 
due to exposure to increased afterload, and that mechan-
ical stress associated with structural changes of the para-
doxical septal motion caused fibrosis in the SIPs [25]. 
Afterwards, continuous increases in the afterload to the 
RV triggered inflammation, which in turn progressed to 
RV free wall fibrosis, and eventually exacerbated RV dys-
function [12].
While prior studies showed modest increase in the 
fibrosis of the RV free wall in human PH patients than in 
controls [26, 27], we noted obviously increased fibrosis in 
the RV free wall in the later stages of PH compared to the 
baseline. The timing of the tissue sampling might explain 
these differences because we observed more severe fibro-
sis in the RV free wall later in the disease. In addition, we 
used monocrotaline to induce PH in the study animals. 
This is a simple and reliable method to induce PH in ani-
mal models and its results resemble the vasculopathy of 
human pulmonary arterial hypertension [16, 17]. How-
ever, monocrotaline-induced PH shows rapid disease 
progression over several weeks in contrast to human PH, 
which evolves slowly over years. Therefore, the process 
of myocardial fibrosis might be different for animals and 
humans. Further, monocrotaline could induce myocardi-
tis in animals. However, while the induction dose of myo-
carditis is known to be 50-60 mg/kg, we used 40 mg/kg in 
the study. In addition, significant increases in myocardial 
native T1 and ECV values were not observed in the LV 
according to disease duration. Therefore, direct myocar-
dial injury from monocrotaline might be insignificant in 
the present study.
Limitations
Our study has limitations. First, we did not perform a lon-
gitudinal observation because frequent administration of 
anesthesia for CMR scanning often leads to the death of 
animals with PH, and that would have impeded the pro-
gress of our study. However, because the effect of mono-
crotaline has been reported to be constant throughout 
time in previous reports [16], the serial changes observed 
in this study might be acceptable. Second, a variety of 
different histological methods are currently used to 
quantify collagen in myocardial fibrosis, and the amount 
of estimated collagen density can vary slightly depend-
ing on the quantification method [28]. Third, we meas-
ured native T1 and ECV values with CMR and collagen 
density with histologic specimens in the middle one third 
level of the RV to match the corresponding locations. 
However, slight differences might have been present.
Conclusions
We observed the sequential progression of RV free wall 
fibrosis with time to time variations in an animal model 
with PH using CMR native T1 mapping and ECV; find-
ings well correlated with histological analysis. As 
described previously, RV free wall fibrosis is a highly 
dynamic process, which can be reversed after lung trans-
plantation or pulmonary endarterectomy. Therefore, 
further studies are needed to determine whether the T1 
mapping technique can be used to evaluate the reversi-
bility of RV free wall fibrosis. In addition, the T1 mapping 
technique needs to be developed further for humans with 
larger scales of investigation before we can determine 
the clinical value of the T1 mapping technique for RV 
free wall fibrosis. New technical developments and sub-
sequent findings might provide new perspectives on PH 
and help clinicians develop more management strategies 
for PH patients in the future.
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